Status:
COMPLETED
Management of Cardiovascular Risk Factors
Lead Sponsor:
AstraZeneca
Conditions:
Cardiovascular Risk Factors
Cardiovascular Diseases
Eligibility:
All Genders
Brief Summary
This practical experience should report a retrospective collection of data regarding cardiovascular risk factors of cardiovascular diseases. The goal is an evaluation of the development of the risk pr...
Eligibility Criteria
Inclusion
- Patients received a anti-hypertension treatment in addition to cholesterol lowering treatment during the observation period
- Patients received a cholesterol lowering treatment in addition to hypertension treatment during the observation period
- Patients received during the observation time new cholesterol lowering and hypertension treatment
Exclusion
- Patients received during the observation time only cholesterol lowering or only anti-hypertension treatment
Key Trial Info
Start Date :
February 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
1492 Patients enrolled
Trial Details
Trial ID
NCT00848380
Start Date
February 1 2009
End Date
December 1 2009
Last Update
November 16 2010
Active Locations (36)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Frick, Canton of Aargau, Switzerland
2
Research Site
Neuenhof, Canton of Aargau, Switzerland
3
Research Site
Riehen, Canton of Basel-City, Switzerland
4
Research Site
Thun, Canton of Bern, Switzerland